ARHGAP32
Basic information
Region (hg38): 11:128965060-129279324
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ARHGAP32 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 25 | 10 | 35 | |||
missense | 99 | 113 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 3 | 3 | ||||
non coding | 2 | |||||
Total | 0 | 0 | 99 | 34 | 17 |
Variants in ARHGAP32
This is a list of pathogenic ClinVar variants found in the ARHGAP32 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-128968913-T-C | ARHGAP32-related disorder | Likely benign (Oct 01, 2022) | ||
11-128968914-G-A | not specified | Uncertain significance (Jun 13, 2024) | ||
11-128968955-G-A | ARHGAP32-related disorder | Benign/Likely benign (Mar 01, 2022) | ||
11-128968965-G-A | ARHGAP32-related disorder | Uncertain significance (Aug 01, 2023) | ||
11-128968974-C-T | not specified | Uncertain significance (Jan 23, 2024) | ||
11-128968979-C-T | Likely benign (Aug 20, 2018) | |||
11-128969041-C-T | ARHGAP32-related disorder | Likely benign (Apr 17, 2023) | ||
11-128969086-A-C | not specified | Uncertain significance (Feb 28, 2024) | ||
11-128969094-A-G | not specified | Uncertain significance (Mar 19, 2024) | ||
11-128969103-T-C | not specified | Uncertain significance (May 09, 2023) | ||
11-128969143-G-A | not specified | Uncertain significance (Dec 08, 2022) | ||
11-128969154-T-A | not specified | Uncertain significance (Feb 05, 2024) | ||
11-128969156-G-A | Likely benign (Oct 13, 2017) | |||
11-128969230-G-T | not specified | Uncertain significance (Jul 19, 2022) | ||
11-128969231-G-T | ARHGAP32-related disorder | Likely benign (Apr 15, 2019) | ||
11-128969239-C-T | not specified | Uncertain significance (Sep 27, 2021) | ||
11-128969248-G-C | not specified | Uncertain significance (Sep 06, 2022) | ||
11-128969261-T-C | ARHGAP32-related disorder | Benign (Jan 17, 2020) | ||
11-128969271-T-C | not specified | Uncertain significance (Aug 31, 2022) | ||
11-128969277-T-C | not specified | Uncertain significance (Sep 22, 2022) | ||
11-128969305-G-A | not specified | Uncertain significance (Apr 08, 2024) | ||
11-128969315-C-A | not specified | Uncertain significance (Dec 06, 2023) | ||
11-128969381-G-A | ARHGAP32-related disorder | Likely benign (Feb 28, 2019) | ||
11-128969385-G-A | not specified | Uncertain significance (Aug 13, 2021) | ||
11-128969445-T-C | not specified | Uncertain significance (Jun 17, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ARHGAP32 | protein_coding | protein_coding | ENST00000310343 | 22 | 314265 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.000225 | 125712 | 0 | 36 | 125748 | 0.000143 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.81 | 976 | 1.15e+3 | 0.850 | 0.0000640 | 13629 |
Missense in Polyphen | 316 | 439.87 | 0.7184 | 5035 | ||
Synonymous | 0.369 | 427 | 437 | 0.978 | 0.0000251 | 4185 |
Loss of Function | 7.02 | 13 | 81.3 | 0.160 | 0.00000447 | 1019 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000296 | 0.000296 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000329 | 0.000326 |
Finnish | 0.0000924 | 0.0000924 |
European (Non-Finnish) | 0.000117 | 0.000114 |
Middle Eastern | 0.000329 | 0.000326 |
South Asian | 0.000166 | 0.000163 |
Other | 0.000165 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: GTPase-activating protein (GAP) promoting GTP hydrolysis on RHOA, CDC42 and RAC1 small GTPases. May be involved in the differentiation of neuronal cells during the formation of neurite extensions. Involved in NMDA receptor activity-dependent actin reorganization in dendritic spines. May mediate cross-talks between Ras- and Rho-regulated signaling pathways in cell growth regulation. Isoform 2 has higher GAP activity (By similarity). {ECO:0000250, ECO:0000269|PubMed:12446789, ECO:0000269|PubMed:12454018, ECO:0000269|PubMed:12531901, ECO:0000269|PubMed:12788081, ECO:0000269|PubMed:12819203, ECO:0000269|PubMed:12857875, ECO:0000269|PubMed:17663722}.;
- Pathway
- Signal Transduction;Rho GTPase cycle;Signaling by Rho GTPases;EGFR1;Neurotrophic factor-mediated Trk receptor signaling
(Consensus)
Intolerance Scores
- loftool
- 0.375
- rvis_EVS
- -2.15
- rvis_percentile_EVS
- 1.45
Haploinsufficiency Scores
- pHI
- hipred
- Y
- hipred_score
- 0.628
- ghis
- 0.528
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.539
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Arhgap32
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cellular phenotype;
Gene ontology
- Biological process
- small GTPase mediated signal transduction;positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction
- Cellular component
- Golgi membrane;fibrillar center;nucleoplasm;endoplasmic reticulum membrane;Golgi apparatus;cytosol;cell cortex;endosome membrane;postsynaptic density;actin cytoskeleton;cell junction;dendritic spine;postsynaptic membrane
- Molecular function
- GTPase activator activity;protein binding;phosphatidylinositol binding